tofogliflozin and its Impurities
Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.